ATS View
한국어

Coreline Soft KRX:384470KOSDAQ

코어라인소프트 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h13
Articles, 7 days16
DART filings, 7 days0
Articles tracked16since Sep 11

In Q2 2026, Coreline Soft reported an operating loss of ₩2.4bn. Coreline Soft (코어라인소프트) appeared in 16 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 16 articles. The most common catalyst was clinical & approvals (1).

Coreline Soft quarterly results consolidated, KRW

QuarterOperating profitNet income
Q2 2026−₩2.4bn−₩3.7bn
Q1 2026−₩3.1bn−₩3.2bn
Q4 2025 derived−₩2.9bn−₩3.2bn
Q3 2025−₩3.6bn−₩3.7bn
Q2 2025−₩3.2bn−₩3.6bn
Q1 2025−₩3.7bn−₩4.0bn
Q4 2024 derived−₩3.7bn−₩4.4bn
Q3 2024−₩3.4bn−₩3.6bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Coreline Soft top stories 2 weeks, by number of outlets

  1. 1
    코어라인소프트, '폐결절 CAD' 일본PMDA 승인
    3 outlets · 3 articlesFirst report Sep 14 14:54 뉴시스경제
  2. 2
    코어라인소프트, 일본서 폐결절 AI 승인…현지 사업 확대
    2 outlets · 2 articlesFirst report Sep 14 15:10 조선비즈
  3. 3
    6년 공들인 코어라인소프트…日서 자체 폐결절 AI로 시장 공략 본격화
    1 outlets · 2 articlesFirst report Sep 14 11:01 이데일리
  4. 4
    코어라인소프트, ‘에이뷰 렁 노듈 CAD’ 日 PMDA 승인 획득
    1 outlets · 1 articlesFirst report Sep 14 17:30 라포르시안Regulatory approval
  5. 5
    코어라인소프트 ‘AVIEW’, 일본 PMDA 승인…80개 병원 기반 사업 확대
    1 outlets · 1 articlesFirst report Sep 14 17:11 메디컬투데이
  6. 6
    코어라인소프트, 국내외 전문가와 韓·EU 폐암 AI 검진 운영 경험 공유
    1 outlets · 1 articlesFirst report Sep 14 11:07 더바이오

Latest Coreline Soft news Korean headlines